Advertisement

Topics

Latest "PrIME Biologics Private Limited" News Stories

20:59 EDT 24th September 2018 | BioPortfolio

Here are the most relevant search results for "PrIME Biologics Private Limited" found in our extensive news archives from over 250 global news sources.

More Information about PrIME Biologics Private Limited on BioPortfolio

In addition to our news stories we have dozens of PubMed Articles about PrIME Biologics Private Limited for you to read. Along with our medical data and news we also list PrIME Biologics Private Limited Clinical Trials, which are updated daily. BioPortfolio also has a large database of PrIME Biologics Private Limited Companies for you to search.

Showing "PrIME Biologics Private Limited" News Articles 1–25 of 12,000+

Monday 24th September 2018

MATRIXX: First Ever Clinical Trial Evaluating 3D-Printed Titanium vs PEEK

Nexxt Spine LLC, a medical device company focused on designing, manufacturing, and distributing innovative spinal solutions, announces the momentous start of the MATRIXX Trial – marking the first ever clinical evaluation of novel 3D-printed lumbar interbody fusion devices relative to PEEK. The Nexxt Matrixx® System is a collection of porous tit...


CareStack secures $16M to enhance cloud-based platform for dental offices

In addition to the funding, which was led by Accel, Eight Roads Ventures and F-Prime Capital Partners, the company announced it has opened a new office in Cambridge, Massachusetts.

Limacorporate SpA Medical Equipment Deals and Alliances Profile [Report Updated: 11052018] Prices from USD $250

SummaryLimacorporate SpA Lima is a medical device company that offers reconstructive and fixation orthopaedic solutions. The company offers large joint primary, large joint revision, extremities and fixation and promade products. It offers medical products for knee, hip, shoulder, cups, small joints and trauma, and others. Lima offers solutions to assist orthopedic surgeons in restoring the emotio...


Anthem Blue Cross Blue Shield Rated Among Top Health Plans in Maine by NCQA

Anthem Blue Cross and Blue Shield in Maine received a rating of 4.5 out of 5 in the recently released National Committee for Quality Assurance (NCQA) Private Health Insurance Plan Ratings 2017-2018, making it a top-ranked plan in the state. The NCQA, a nonprofit organization dedicated to improving health care quality, publicly released its 2018-19...

On solving the brain: Ed Boyden and the new neuroscience

On Ed Boyden’s Twitter feed, you’ll find a picture of him with Canadian Prime Minister Justin Trudeau. Boyden, wearing a blazer, no tie, and glasses, holds up a Petri dish as Trudeau, sleeves rolled up and tie loosened, leans in […] The post On solving the brain: Ed Boyden and the new neuroscience appeared first on SynBioBeta.

Estimated 2.5% of U.S. Kids Have Had TBI in Their Lifetime

(MedPage Today) -- Prevalence is higher in states with higher estimates of private health insurance

Dignity Health California Hospital Medical Center to Construct Patient Care Tower as Centerpiece of Campus Expansion

New Tower Will Allow Hospital to Continue its Mission of Service to All While Enhancing Capacity and Accessibility for Emergency, Trauma and Maternity Services Dignity Health California Hospital Medical Center (CHMC) announced today plans to construct a new patient care tower that will serve as the centerpiece of a $215 million campus expansi...

Today the @globalcompact launched a new action platform - Health is Everyone’s Business - to set a global business agenda for #SDG3. We are motivated to be participating to help private and public organisations to drive #sustainablehealth #UNGA http://

Today the @globalcompact launched a new action platform - Health is Everyone’s Business - to set a global business agenda for #SDG3. We are motivated to be participating to help private and public organisations to drive #sustainablehealth #UNGA

Hangzhou TianMuShan Pharmaceutical Enterprise Co Ltd 600671 Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 17042018] Prices from USD $250

SummaryHangzhou TianMuShan Pharmaceutical Enterprise Co Ltd Hangzhou is a pharmaceutical company that manufactures and distributes pharmaceuticals, healthcare products, medical equipment and electronic products. The company offers products, which include dendrobium plantlets, dendrobium fresh goods, dendrobium particles, banxialu syrup, jingguishenqi pill, six huang wan, gift dendrobium soft capsu...

Anthem Blue Cross Blue Shield Rated Top Health Plan in Connecticut by NCQA

Anthem Blue Cross and Blue Shield in Connecticut received a rating of 4.5 out of 5 in the recently released National Committee for Quality Assurance (NCQA) Private Health Insurance Plan Ratings 2018-2019, making it the top-ranked health plan in the state. The NCQA, a nonprofit organization dedicated to improving healthcare quality, publicly releas...

Baron & Budd Investigating Medicare and Medicaid Fraud in Patient Assistance Programs for Specialty Drugs

Whistleblowers play key role highlighting fraudulent charities that target public insurance programs Today, the national law firm Baron & Budd announced that it is dedicating significant resources from its whistleblower practice to the investigation of Medicare and Medicaid fraudulent kic

Batu Biologics Announces the Release of the Starve The Tumor Immunotherapy Blog

Clinical Stage Immuno-Oncology Company Releases Media Platform to Provide Background Information on Lead Technology Today, Batu Biologics announced the release of the Starve The Tumor Video Blog, a series of informational videos and articles designed to provide background information on our lead therapeutic ValloVax. Batu Biologics’ lead clinical can...

Anthem Blue Cross and Blue Shield Rated Top in Indiana by NCQA

Anthem Blue Cross and Blue Shield in Indiana’s private plan placed top in the state and its Medicaid plan shared the top ranking in the recently released National Committee for Quality Assurance (NCQA) Health Insurance Plan Ratings 2018-2019. The NCQA, a nonprofit organization dedicated to improving healthcare quality, publicly released its 2018...

Arrowhead Pharmaceuticals to Host R&D Day on Emerging Pipeline of RNAi Therapeutics

Arrowhead Pharmaceuticals Inc. (NASDAQ: ARWR) today announced that it will host a Research & Development (R&D) Day to discuss its emerging pipeline of RNAi therapeutics that leverage its proprietary Targeted RNAi Molecule (TRIMTM) platform on October 16, 2018 in New York City. The R&D Day will feature presentations by Ira Goldberg, M.D...

Tailwind Capital Closes Fund III with $1.8 Billion of Commitments

Tailwind Capital (“Tailwind”), a middle market private equity firm investing in targeted sectors within healthcare, business services and industrial services, has closed Tailwind Capital Partners III, L.P. (together with its related funds, “Fund III” or the “Fund”) at $1.8 billion of commitments. The Fund exceeded its initial target and was ove...

Great Hill Partners Successfully Exits Ascenty in $1.8 Billion-Plus Transaction

BOSTON, Sept. 24, 2018 /PRNewswire/ -- Great Hill Partners, a leading growth-oriented private equity firm, today announced that it has entered into a definitive agreement Read more...

Biofrontera AG: Biofrontera to Present at the Cantor Fitzgerald Global Healthcare Conference

DGAP-News: Biofrontera AG / Key word(s): Conference 24.09.2018 / 10:38 The issuer is solely responsible for the content of this announcement. Biofrontera to Present at the Cantor Fitzgerald Global Healthcare Conference Leverkusen, Germany, September 24, 2018 - Biofrontera AG (NASDAQ: BFRA; Frankfurt Stock Exchange: B8F), an international biopharmaceutical company, today announced that ...

Laboratorios Del Dr Esteve SA Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 06072018] Prices from USD $250

SummaryLaboratorios Del Dr Esteve SA Esteve researches, develops and markets prescription and generic pharmaceutical products. The company's product portfolio encompasses innovative prescription drugs, overthecounter OTC pharmaceuticals and generic drugs. It offers drugs in central nervous system, infection, respiratory, cardiovascular, cancer, primary care and other therapeutic areas. Esteve also...

SOM Biotech SL Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 14062018] Prices from USD $250

SummarySOM Biotech SL SOM Biotech is a drug repurposing company that discovers and develops new drugs for orphan indications. The company's pipeline products include SOM0777, SOM0226, SOM3355, SOM1201 and SOM2201 are used for the treatment of TTR amyloidosis, glioblastoma, huntington disease, duchenne muscular dystrophy and adrenoleukodystrophy. It also provides services such as drug discovery, pa...

Symbiosis Secures FDA Approval

For its viral vector manufacturing fill/finish process at its biologics manufacturing facility located in Scotland, UK

AGC Biologics Announces New Facility

The process development & manufacturing site will contain single-use bioreactors at the 500 and 2000L scale

Excelera® Specialty Pharmacy Network Announces Partnership with Smith & Nephew

ExceleraRx Corp. announced a partnership with Smith & Nephew for advanced wound care management products used in the treatment of acute and chronic wounds. These products will be made available through Excelera to health system specialty pharmacies. MINNEAPOLIS (PRWEB) September 24, 2018 The Excelera network consists of point-of-care specialty pharmacies owned by health systems and academic m...

Audentes Therapeutics Inc BOLD Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 12042018] Prices from USD $250

SummaryAudentes Therapeutics Inc Audentes is a biotechnology company that focuses on the development and commercialization of gene therapy products for serious and lifethreatening rare diseases. The company's pipeline products include AT132, intended for the treatment of Xlinked myotubular myopathy; AT982, for the treatment of Pompe disease; AT342, for the treatment of criglernajjar syndrome; and ...

Global AntiViral Therapeutics Market Segmented by Drug Type, Distribution Channel Growth, Trends and Forecasts 2018 2023 [Report Updated: 01032018] Prices from USD $4250

The global antiviral Therapeutics market is expected to register a CAGR of 6.2% during the forecast period, 2018 to 2023. North America dominates the market due to growing prevalence of Hepatitis C HIV infections, coupled with the presence of huge patient pool suffering from virally infectious diseases.High Prevalence of Different Viral InfectionAccording to the World Health Organization WHO, it ...

Midatech Pharma Plc MTPH Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 13042018] Prices from USD $250

SummaryMidatech Pharma Plc Midatech is a pharmaceutical company that develops and commercialize oncology and other therapeutic products. The company's products include gelclair, oravig, soltamox, zuplenz, ferralet 90 and aquoral. It conducts research and development programs in areas of oncology, autoimmune diseases, pipeline, Qoctreotide, opsisporin, HCC, glioblastoma and diabetes vaccine. Midate...


Advertisement
Quick Search
Advertisement
Advertisement

 

News Quicklinks